• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder.

作者信息

Brackmann H H, Gormsen J

出版信息

Lancet. 1977 Oct 29;2(8044):933. doi: 10.1016/s0140-6736(77)90871-6.

DOI:10.1016/s0140-6736(77)90871-6
PMID:72276
Abstract
摘要

相似文献

1
Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder.在患有因子VIII抑制剂的高反应性血友病患者中大量输注因子VIII
Lancet. 1977 Oct 29;2(8044):933. doi: 10.1016/s0140-6736(77)90871-6.
2
Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
Haemophilia. 2010 May;16(102):2-3. doi: 10.1111/j.1365-2516.2010.02266.x.
3
Commentary on Brackmann and Gormsen (Lancet 1977; ii: 933): Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder.
Haemophilia. 2010 May;16(102):4-5. doi: 10.1111/j.1365-2516.2010.02237.x.
4
Successful treatment with prothrombin complex concentrate of postoperative bleeding in a haemophiliac with a factor VIII inhibitor.用凝血酶原复合物浓缩剂成功治疗一名患有VIII因子抑制剂的血友病患者术后出血。
Br Med J. 1976 Nov 6;2(6044):1110-1. doi: 10.1136/bmj.2.6044.1110-a.
5
Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.伴有因子VIII和因子IX抑制剂的血友病、发病率、出血问题及管理
Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:106-12.
6
Resistance to activated F IX concentrate (FEIBA).对活化凝血因子IX浓缩物（FEIBA）的耐药性。
Scand J Haematol. 1977 May;18(5):421-6. doi: 10.1111/j.1600-0609.1977.tb02096.x.
7
Hemophiliacs with inhibitors: therapeutic options.患有抑制物的血友病患者：治疗选择
N Engl J Med. 1981 Sep 24;305(13):757-8. doi: 10.1056/NEJM198109243051308.
8
Surgery in haemophilic patients with inhibitors.伴有抑制物的血友病患者的手术治疗
Haemophilia. 2004 Sep;10 Suppl 2:1-2. doi: 10.1111/j.1365-2516.2004.00933.x.
9
[Experience from the Hemophilia Clinic. 3. Intramuscular hemorrhages in hemophilia].
Ned Tijdschr Geneeskd. 1970 Apr 25;114(17):719-22.
10
The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors.使用凝血因子 VIII 抑制物旁路活性制剂（FEIBA免疫）产品治疗有抑制物的血友病患者的出血发作。
Blood. 1983 Jan;61(1):36-40.

引用本文的文献

1
Adeno-associated virus-vectored delivery of HIV biologics: the promise of a "single-shot" functional cure for HIV infection.腺相关病毒载体递送HIV生物制剂：实现HIV感染“单次注射”功能性治愈的前景。
J Virus Erad. 2023 Feb 17;9(1):100316. doi: 10.1016/j.jve.2023.100316. eCollection 2023 Mar.
2
Assessing the value of bypassing agent therapy used prophylactic versus on-demand, during immune tolerance induction for treatment of inhibitors: a retrospective chart review.评估在免疫耐受诱导治疗抑制剂期间预防性而非按需使用旁路制剂的价值：一项回顾性图表审查。
Orphanet J Rare Dis. 2023 Mar 7;18(1):47. doi: 10.1186/s13023-023-02654-0.
3
Until programmed death do us tolerant.
直到程序性死亡让我们宽容。
J Clin Invest. 2022 Nov 15;132(22):e164858. doi: 10.1172/JCI164858.
4
Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ Tregs.输入的 FVIII 在血友病 A 中诱导的免疫耐受由 PD-L1+Treg 介导。
J Clin Invest. 2022 Nov 15;132(22):e159925. doi: 10.1172/JCI159925.
5
Immune complications and their management in inherited and acquired bleeding disorders.遗传性和获得性出血性疾病的免疫并发症及其处理。
Blood. 2022 Sep 8;140(10):1075-1085. doi: 10.1182/blood.2022016530.
6
Haemophilia.血友病。
Nat Rev Dis Primers. 2021 Jun 24;7(1):45. doi: 10.1038/s41572-021-00278-x.
7
Origins, Development, Current Challenges and Future Directions with Activated Prothrombin Complex Concentrate for the Treatment of Patients with Congenital Haemophilia with Inhibitors.活化的凝血酶原复合物浓缩物治疗伴有抑制剂的先天性血友病患者的起源、发展、当前挑战和未来方向。
Hamostaseologie. 2020 Dec;40(5):606-620. doi: 10.1055/a-1159-4273. Epub 2020 Jul 27.
8
Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A.AAV 肝靶向因子 VIII 基因治疗诱导免疫耐受治疗血友病 A 的转化潜力。
Front Immunol. 2020 Apr 28;11:618. doi: 10.3389/fimmu.2020.00618. eCollection 2020.
9
Suppression of FVIII-Specific Memory B Cells by Chimeric BAR Receptor-Engineered Natural Regulatory T Cells.嵌合 BAR 受体工程化天然调节性 T 细胞抑制 FVIII 特异性记忆 B 细胞。
Front Immunol. 2020 Apr 21;11:693. doi: 10.3389/fimmu.2020.00693. eCollection 2020.
10
The Immune Response to the fVIII Gene Therapy in Preclinical Models.在临床前模型中对 fVIII 基因治疗的免疫反应。
Front Immunol. 2020 Apr 15;11:494. doi: 10.3389/fimmu.2020.00494. eCollection 2020.